Neurotransmitter Systems in Alzheimer’s Disease

No abstract is available for this paper.

• Publication year

  1986

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/978-1-349-08639-9_7
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Somatostatin immunoreactivity in neuritic plaques of Alzheimer's patients

  1985cited by this paper
• Somatostatin-like immunoreactivity within neuritic plaques.

  1985cited by this paper
• Dementia of different etiologies

  1985cited by this paper
• Immunocytochemical Studies of Substance P and Met‐Enkephalin in the Basal Ganglia and Substantia Nigra in Huntington's, Parkinson's and Alzheimer's Diseases

  1985cited by this paper
• Elevation of neuropeptide Y (NPY) in substantia innominata in Alzheimer's type dementia.

  1984cited by this paper
• Mapping of enkephalins in human brain: an immunohistofluorescence study on brains from patients with senile and presenile dementia

  1984cited by this paper
• Coexistence of neuropeptide Y and somatostatin in rat and human cortical and rat hypothalamic neurons.

  1984cited by this paper
• Two types of cholinergic innervation in cortex, one co-localized with vasoactive intestinal polypeptide

  1984cited by this paper
• Cholecystokinin octapeptide in dementia.

  1984cited by this paper
• Somatostatin and vasoactive intestinal polypeptide in postmortem brains from patients with Alzheimer-type dementia.

  1984cited by this paper
• Neurotransmitter dysfunction and atrophy of the caudate nucleus in Alzheimer's disease.

  1984cited by this paper
• Biochemical substrates of mental disturbances in Parkinson's disease.

  1984cited by this paper
• Implications of neuropeptides in neurological diseases.

  1984cited by this paper
• GABAergic neurons of mammalian cerebral cortex: widespread subclass defined by somatostatin content.

  1984cited by this paper
• Effect of Age on Human Brain Serotonin (S‐1) Binding Sites

  1984cited by this paper
• Cholecystokinin-8-like immunoreactivity in the pre- and post-central gyri of the human cerebral cortex.

  1984cited by this paper
• Serotonin Receptor Changes in Dementia of the Alzheimer Type

  1984cited by this paper
• Studies on neurotransmitter receptor systems in neocortex and hippocampus in senile dementia of the Alzheimer-type.

  1984cited by this paper
• Immunohistochemical distribution of pro-somatostatin-related peptides in cerebral cortex.

  1983cited by this paper
• Monoamine metabolism in senile dementia of Alzheimer type.

  1983cited by this paper
• Somatostatin and dementia in Parkinson's disease.

  1983cited by this paper
• Catecholamines and cholinergic enzymes in pre-senile and senile Alzheimer-type dementia and Down's syndrome.

  1983cited by this paper
• Neuropeptides in Alzheimer type dementia.

  1983cited by this paper
• Alzheimer's disease: a disorder of cortical cholinergic innervation.

  1983cited by this paper
• Oral physostigmine and lecithin improve memory in Alzheimer's disease.

  1983cited by this paper
• Neuropeptide Y distribution in human brain

  1983cited by this paper
• Basal nucleus of Meynert: a neuropathological study in Alzheimer's disease, simple senile dementia, Pick's disease and Huntington's chorea.

  1983cited by this paper
• Presynaptic Cholinergic Dysfunction in Patients with Dementia

  1983cited by this paper
• Loss of pigmented dopamine-β-hydroxylase positive cells from locus coeruleus in senile dementia of alzheimer's type

  1983cited by this paper
• Amino acid release from biopsy samples of temporal neocortex from patients with Alzheimer's disease.

  1983cited by this paper
• Oral physostigmine in Alzheimer's disease.

  1983cited by this paper
• Thyrotropin-releasing hormone, luteinizing hormone-releasing hormone and substance P immuno-reactivity in post-mortem brain from cases of Alzheimer-type dementia and Down's syndrome.

  1983cited by this paper
• Serotonin nerve cells in Alzheimer's disease.

  1983cited by this paper
• A post-mortem study of the cholinergic and GABA systems in senile dementia.

  1982cited by this paper
• Extensive loss of choline acetyltransferase activity is not reflected by neuronal loss in the nucleus of Meynert in Alzheimer's disease.

  1982cited by this paper
• The noradrenergic system in Alzheimer and multi-infarct dementias.

  1982cited by this paper
• Cortical Substance P‐Like Immunoreactivity in Cases of Alzheimer's Disease and Senile Dementia of the Alzheimer Type

  1982cited by this paper
• Alzheimer's disease as a disorder of isodendritic core.

  1982cited by this paper
• The cholinergic hypothesis of geriatric memory dysfunction.

  1982cited by this paper
• The substantia innominata in Alzheimer's disease: an histochemical and biochemical study of cholinergic marker enzymes.

  1982cited by this paper
• Cholinergic innervation in neuritic plaques.

  1982cited by this paper
• Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain.

  1982cited by this paper
• Neuropeptides in degenerative disease of the central nervous system

  1982cited by this paper
• Neuropeptides in Alzheimer's disease, depression and schizophrenia. A post mortem analysis of vasoactive intestinal peptide and cholecystokinin in cerebral cortex.

  1981cited by this paper
• Cortical somatostatin-like immunoreactivity in cases of Alzheimer's disease and senile dementia of the Alzheimer type.

  1981cited by this paper
• Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis

  1981cited by this paper
• Selective loss of neurones of origin of adrenergic projection to cerebral cortex (nucleus locus coeruleus) in senile dementia.

  1981cited by this paper
• Cell loss in the locus coeruleus in senile dementia of Alzheimer type.

  1981cited by this paper
• Role of glutamate and zinc in the hippocampal lesions of Pick's disease.

  1981cited by this paper
• Alzheimer-like cholinergic deficiency in Down syndrome.

  1980cited by this paper
• Biogenic amines in human brain in normal aging, senile dementia, and chronic alcoholism.

  1980cited by this paper
• Hippocampal Free Amino Acids in Alzheimer's Disease

  1980cited by this paper
• Reduced cortical choline acetyltransferase activity in senile dementia of Alzheimer type is not accompanied by changes in vasoactive intestinal polypeptide.

  1980cited by this paper
• Reduced amounts of immunoreactive somatostatin in the temporal cortex in senile dementia of Alzheimer type.

  1980cited by this paper
• Neurotransmitter-related enzymes in senile dementia of the Alzheimer type.

  1979cited by this paper
• Occurrence of vasoactive intestinal polypeptide (VIP)-like immunoreactivity in certain cholinergic neurons of the cat: evidence from combined immunohistochemistry and acetylcholinesterase staining.

  1979cited by this paper
• Localization and molecular heterogeneity of cholecystokinin in the central and peripheral nervous system.

  1979cited by this paper
• Changes in the Brain Catecholamines in Patients with Dementia of Alzheimer Type

  1979cited by this paper
• Peptides as neurotransmitter candidates in the mammalian cns

  1979cited by this paper
• MODULATION OF THE TURNOVER RATE OF ACETYLCHOLINE IN RAT BRAIN BY INTRAVENTRICULAR INJECTIONS OF THYROTROPIN‐RELEASING HORMONE, SOMATOSTATIN, NEUROTENSIN AND ANGIOTENSIN II

  1978cited by this paper
• Radioimmunoassay of vasoactive intestinal polypeptide (VIP) in plasma.

  1978cited by this paper
• 2-Dimethylaminoethanol (Deanol) in Huntington's chorea

  1978cited by this paper
• Pre- and postsynaptic neurochemical alterations in Alzheimer's disease.

  1978cited by this paper
• HOMOVANILLIC ACID AND 5‐HYDROXYINDOLEACETIC ACID IN THE CEREBROSPINAL FLUID OF PATIENTS WITH SENILE DEMENTIA, PRESENILE DEMENTIA AND PARKINSONISM

  1969cited by this paper
• Fluorescent antibody methods

  1968cited by this paper

• Biological Signatures of Disease in Neuro-Psychiatry as Inter-Theoretical Reduction.

  2020cites this paper
• Asymmetric increase in substance P immunoreactivity in the rat and guinea pig substantia nigra after unilateral neocortical ablation.

  1991cites this paper